Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Smooth Drug Development Selects CRO Starter Kit™ CTMS by Flex Databases

Published: Monday, September 23, 2013
Last Updated: Monday, September 23, 2013
Bookmark and Share
Flex Databases to release an electronic data capture (EDC) product in Q4 2013.

Flex Databases has announced that Smooth Drug Development has selected Flex CRO Starter Kit™ as its CTMS solution.

Smooth Drug Development is a full-service CRO headquartered in St. Petersburg, Russia. Smooth performs phase I-IV studies and runs 2 phase I units in St. Petersburg.

"We looked at a number of solutions on the market", said Dmitry Morozovsky, CEO of Smooth Drug Development. "In Flex Databases we found a solution which gives us the breadth of functionality we have not seen before, as Flex provide both PSA (such as timesheets, budgets, planning, utilization) and clinical research tools on the same platform. What especially caught our attention is the fact that Flex Databases are going to be releasing an electronic data capture (EDC) product in Q4 2013. We run a lot of bioequivalence studies, where operational efficiency is crucial, and having a single platform bringing together resource management, CTMS and EDC will allow us to shorten study timelines and further improve performance on the studies we run."

"Smooth Drug Development are a forward looking dynamic company who were quick to see the value of our platform", said Timur Galimov, Technical Director at Flex Databases.

Galimov continued, "We come across a lot of interest towards our upcoming EDC product, and we are pleased to have found an early adopter of our EDC technology even before the product has been released. Smooth Drug Development have one of the most comprehensive offerings we have seen in clinical research, and we are keen to help them grow by offering a platform which will streamline all the processes of their business".


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flex Databases Launches New Web Site
New website cements the company's unique positioning as a PSA company.
Tuesday, March 25, 2014
Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!